imatinib mesylate has been researched along with Hypothyroidism in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cano Megías, M; Carrasco De La Fuente, M; González Albarrán, O; Menacho Román, M; Pérez López, G | 1 |
de Groot, JW; Links, TP; Plukker, JT; van Der Graaf, WT; Zonnenberg, BA | 1 |
de Groot, JW; Links, TP; van der Graaf, WT | 1 |
Berets, O; Bladé, JS; Defuentes, G | 1 |
1 trial(s) available for imatinib mesylate and Hypothyroidism
Article | Year |
---|---|
Imatinib induces hypothyroidism in patients receiving levothyroxine.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Medullary; Drug Synergism; Female; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 2005 |
3 other study(ies) available for imatinib mesylate and Hypothyroidism
Article | Year |
---|---|
[Management of hypothyroidism secondary to tyrosine kinase inhibitors: description of treatment in three distinct clinical settings].
Topics: Adult; Benzamides; Benzenesulfonates; Carcinoma, Renal Cell; Choristoma; Female; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Imatinib Mesylate; Indoles; Kidney Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Piperazines; Pleural Diseases; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Sorafenib; Sunitinib; Thymus Gland; Thyroxine | 2011 |
Tyrosine kinase inhibitors causing hypothyroidism in a patient on levothyroxine.
Topics: Aged; Benzamides; Drug Interactions; Female; Humans; Hypothyroidism; Imatinib Mesylate; Indoles; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sunitinib; Thyroid Function Tests; Thyrotropin; Thyroxine | 2006 |
Tyrosine kinase inhibitors for chronic myelogenous leukemia.
Topics: Benzamides; Fusion Proteins, bcr-abl; Humans; Hypothyroidism; Imatinib Mesylate; Indoles; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sunitinib | 2007 |